Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Retained Earnings (2022 - 2025)

Moolec Science (MLECW) posted Retained Earnings of -$44.6 million for Q4 2025, up 60.13% sequentially from -$111.8 million in Q2 2025, and up 36.58% YoY from -$32.6 million in Q4 2024.

Moolec Science (MLECW) Retained Earnings (2022 - 2025) Analysis & Trends

Moolec Science has reported Retained Earnings for 4 years, with the latest figure at -$44.6 million in Q4 2025.

  • Quarterly Retained Earnings rose 36.58% year-over-year to -$44.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$44.6 million (up 36.58% YoY) and the FY2025 annual result came in at -$111.8 million, down 9882.57% from the prior year.
  • Retained Earnings rose to -$44.6 million in Q4 2025 per MLECW's latest filing, from -$111.8 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $1.1 million in Q2 2024 and troughed at -$111.8 million in Q2 2025.
  • A 4-year average of -$54.7 million and a median of -$59.4 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 101.95% in 2024, then slumped 9882.57% in 2025.
  • Over 4 years, Retained Earnings stood at -$55.5 million in 2022, then retreated by 11.67% to -$62.0 million in 2023, then fell by 13.36% to -$70.3 million in 2024, then jumped by 36.58% to -$44.6 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$44.6 million, -$111.8 million, and -$70.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.10 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.05 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -6.33 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 20.91 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.57 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 4.38 Bn
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -44.57 Mn
Jun 30, 2025 -111.79 Mn
Dec 31, 2024 -70.28 Mn
Sep 30, 2024 -67.85 Mn
Jun 30, 2024 1.14 Mn
Mar 31, 2024 -63.40 Mn
Dec 31, 2023 -62.00 Mn
Sep 30, 2023 -60.21 Mn
Jun 30, 2023 -58.62 Mn
Mar 31, 2023 -55.88 Mn
Dec 31, 2022 -55.52 Mn
Jun 30, 2022 -6.83 Mn